Ebilfumin
Active substance: oseltamivir
oseltamivir
Centralised EU authorisationActive
Marketing holder: Actavis Group PTC ehf
Verified 2026-10-09 · EMA
Analogues in other countries- Source: EMA
- Countries with the substance registered: 3
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 47 |
|
| US 128 |
|
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-3034-7cd6-82d8-621a10561b5d,01a120c3-3036-7cd7-a6ba-43b28efdc758,01a120c3-33a3-75e4-8e4f-3edc914a2b48,01a120c3-3b82-7a67-8752-a2978d1520b9,01a120c3-3d90-7730-a727-81b0d475ba76;count=41 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-2ae8-7d35-b559-3d7e224e5359,01a1208c-2cb5-7915-a6be-4bb52995c922,01a1208c-3237-7956-ac3d-78f273ce87ee,01a1208c-507d-7bdc-b4ca-d54a12d2d819,01a1208c-6256-75b5-8edd-3b2d4b7a624f;count=128 · valid from 2026-10-09 · verified 2026-10-09
- Registration number
- EMEA/H/C/003717
- Registration status
- Active
- ATC code
- J05AH02
- product · EMA · EMEA/H/C/003717 · Verified 2026-10-09
- registration_status · EMA · EMEA/H/C/003717 · Verified 2026-10-09
- ingredients.0 · EMA · EMEA/H/C/003717 · Verified 2026-10-09